Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-Density-Lipoprotein-cholesterol Level”

194 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 194 results

Very early researchLooking for participantsNCT06615986
What this trial is testing

Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis

Who this might be right for
Healthy Volunteers
National Heart, Lung, and Blood Institute (NHLBI) 100
Early research (Phase 1)UnknownNCT05839236
What this trial is testing

COVID-19 Vaccination Detoxification in LDL-C

Who this might be right for
COVID-19 Stress SyndromeCOVID-19 Vaccine Adverse ReactionCOVID-19-Associated Thromboembolism+3 more
Yang I. Pachankis 1
Post-approval studies (Phase 4)Study completedNCT03073863
What this trial is testing

Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets Study

Who this might be right for
Cardiovascular Diseases
Korea University Guro Hospital 10,001
Post-approval studies (Phase 4)Study completedNCT02938949
What this trial is testing

Alirocumab in Patients With Acute Myocardial Infarction

Who this might be right for
Myocardial InfarctionHypercholesterolemia
Virginia Commonwealth University 20
Early research (Phase 1)Not Yet RecruitingNCT07074236
What this trial is testing

Pharmacokinetics and Pharmacodynamics Study

Who this might be right for
Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C
Qilu Pharmaceutical Co., Ltd. 48
Not applicableStudy completedNCT03273972
What this trial is testing

INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers

Who this might be right for
AtherosclerosisCardiovascular Diseases
Cambridge University Hospitals NHS Foundation Trust 30
Not applicableStudy completedNCT01547585
What this trial is testing

A Human Trial to Assess the Low Density Lipoprotein Cholesterol (LDL-C) Lowering Effect of Soy

Who this might be right for
HypercholesterolemiaCardiovascular DiseaseCRP
Guelph Food Research Centre 243
Not applicableNot Yet RecruitingNCT07298668
What this trial is testing

Cardiovascular Risk Factors in Middle Eastern Patients With Stroke

Who this might be right for
StrokeLow-Density-Lipoprotein-cholesterol LevelRisk Factors
Jordan Collaborating Cardiology Group 2,000
Not applicableStudy completedNCT01105715
What this trial is testing

Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisCardiovascular Disease
University of Arkansas 100
Testing effectiveness (Phase 2)Study completedNCT02541201
What this trial is testing

The Effect of a Plant Sterols-Enriched Low-Fat Milk on Lipid Profile in Healthy Southern Chinese (COME-PASS)

Who this might be right for
Dyslipidemia
The University of Hong Kong 221
Testing effectiveness (Phase 2)Study completedNCT06173570
What this trial is testing

Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia

Who this might be right for
Dyslipidemia
AstraZeneca 428
Early research (Phase 1)Study completedNCT05905068
What this trial is testing

Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects

Who this might be right for
To Reduce the LDL-C Level in Hypercholesteremia Adult PatientsCombination for Subgroup High LDL-c Patients With Other Comorbidities
Ikaria Bioscience Pty Ltd 32
Not applicableStudy completedNCT02993120
What this trial is testing

Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States

Who this might be right for
Medical Conditions to be StudiedDyslipidemiaASCVD Management
Amgen 5,006
Not applicableStudy completedNCT04271280
What this trial is testing

Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events

Who this might be right for
DyslipidemiaCardiovascular DiseasesHypercholesterolemia+1 more
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 9,559
Early research (Phase 1)Study completedNCT01618916
What this trial is testing

LY3015014 in Otherwise Healthy Participants With High Low-density Lipoprotein (LDL) Cholesterol

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 51
Large-scale testing (Phase 3)Ended earlyNCT01414166
What this trial is testing

Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)

Who this might be right for
Dyslipidemia
Merck Sharp & Dohme LLC 244
Not applicableStudy completedNCT00526058
What this trial is testing

(H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol

Who this might be right for
Hypercholesterolemia
B. Braun Medical Inc. 18
Large-scale testing (Phase 3)Not Yet RecruitingNCT07441317
What this trial is testing

QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 780
Not applicableLooking for participantsNCT03449784
What this trial is testing

Assessment of Compliance With European and French Guidelines for the Management of Dyslipidaemias

Who this might be right for
Patient With Dyslipidemia
University Hospital, Montpellier 977
Testing effectiveness (Phase 2)Study completedNCT07278830
What this trial is testing

A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hypercholesterolemia and Mixed Dyslipidemia
Shenzhen Salubris Pharmaceuticals Co., Ltd. 214
Load More Results